The tumor had estrogen receptor (ER) positivity of 65%, progesterone receptor (PR) positivity of 80%, Ki67 of 15%, and was negative for human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and neoplasm.